PERSPECTA

News from every angle

← Back to headlines

BetterLife Pharma Announces Public Offering for Headache and Migraine Trials

BetterLife Pharma has announced a proposed public offering to secure funding for advancing its clinical trials targeting cluster headaches and migraines.

25 Aug, 06:34 — 25 Aug, 06:34
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed1d ago

BetterLife Pharma announces proposed public offering to advance cluster headache and migraine trials

Read full article →

Related Stories

Hungary's Paks Nuclear Plant Returns to Full Power Output

17m ago

H.C. Wainwright Upgrades Zymeworks Price Target Following FDA Approval

18m ago

Meta Agrees to $18 Billion Settlement in Child Social Media Addiction Lawsuits

30m ago

Deere & Company Announces $1.62 Quarterly Dividend

31m ago